{"id":"https://openalex.org/W7225433364","doi":"https://doi.org/10.1016/j.jcpo.2026.100830","title":"Regulatory pathways for targeted and non-targeted oncology therapies at the European Medicines Agency","display_name":"Regulatory pathways for targeted and non-targeted oncology therapies at the European Medicines Agency","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225433364","doi":"https://doi.org/10.1016/j.jcpo.2026.100830","pmid":"https://pubmed.ncbi.nlm.nih.gov/42994563"},"language":"en","primary_location":{"id":"doi:10.1016/j.jcpo.2026.100830","doi":"https://doi.org/10.1016/j.jcpo.2026.100830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcpo.2026.100830","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2213538326001311/pdf","source":{"id":"https://openalex.org/S2764631794","display_name":"Journal of Cancer Policy","issn_l":"2213-5383","issn":["2213-5383"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Policy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S2213538326001311/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161064958","display_name":"G Puig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"G. Puig","raw_affiliation_strings":["Area of Medicines, Catalan Health Service (CatSalut), Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Area of Medicines, Catalan Health Service (CatSalut), Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161060998","display_name":"Dan\u00e9s","orcid":"https://orcid.org/0000-0002-8711-9666","observed_orcids":["https://orcid.org/0000-0002-8711-9666"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210102407","display_name":"Vall d'Hebron Institut de Recerca","ror":"https://ror.org/01d5vx451","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210102407","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. Dan\u00e9s","raw_affiliation_strings":["Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain; Clinical Pharmacology Service, Vall d'Hebron University Hospital, Barcelona, Spain; Clinical Pharmacology Research Group, Vall d'Hebron Institute of Research, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-8711-9666","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain; Clinical Pharmacology Service, Vall d'Hebron University Hospital, Barcelona, Spain; Clinical Pharmacology Research Group, Vall d'Hebron Institute of Research, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210102407","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161003428","display_name":"C Sans-Pola","orcid":"https://orcid.org/0000-0002-5834-3183","observed_orcids":["https://orcid.org/0000-0002-5834-3183"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I4403928279","display_name":"Fundaci\u00f3 de Recerca Cl\u00ednic Barcelona-Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer","ror":"https://ror.org/041gvmd67","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"C. Sans-Pola","raw_affiliation_strings":["Clinical Pharmacology Service, Hospital Clinic de Barcelona, Barcelona, Spain; Clinical Pharmacology, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-5834-3183","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Service, Hospital Clinic de Barcelona, Barcelona, Spain; Clinical Pharmacology, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4403928279"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5161140848","display_name":"A Vallano","orcid":"https://orcid.org/0000-0002-3648-3492","observed_orcids":["https://orcid.org/0000-0002-3648-3492"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"A. Vallano","raw_affiliation_strings":["Area of Medicines, Catalan Health Service (CatSalut), Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain; Catalan Health Institute, Barcelona, Spain. Electronic address: antoni.vallano@uab.cat"],"raw_orcid":"https://orcid.org/0000-0002-3648-3492","affiliations":[{"raw_affiliation_string":"Area of Medicines, Catalan Health Service (CatSalut), Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona, Cerdanyola de Vall\u00e8s, Barcelona, Spain; Catalan Health Institute, Barcelona, Spain. Electronic address: antoni.vallano@uab.cat","institution_ids":["https://openalex.org/I123044942"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5161140848"],"corresponding_institution_ids":["https://openalex.org/I123044942"],"apc_list":{"value":2760,"currency":"USD","value_usd":2760},"apc_paid":{"value":2760,"currency":"USD","value_usd":2760},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"50","issue":null,"first_page":"100830","last_page":"100830"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7598000168800354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7598000168800354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.06129999831318855,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.028599999845027924,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/conditional-marketing-authorisation","display_name":"conditional marketing authorisation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.6159999966621399},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.6480000019073486},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.8980000019073486},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.675000011920929},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.5856999754905701},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5569999814033508},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.48750001192092896},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3481999933719635},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.3465999960899353},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.2994000017642975},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.29739999771118164},{"id":"https://openalex.org/C2909155969","wikidata":"https://www.wikidata.org/wiki/Q6055890","display_name":"Funding Agency","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.27070000767707825},{"id":"https://openalex.org/C3116431","wikidata":"https://www.wikidata.org/wiki/Q31728","display_name":"Public administration","level":1,"score":0.26899999380111694},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.251800000667572}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jcpo.2026.100830","doi":"https://doi.org/10.1016/j.jcpo.2026.100830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcpo.2026.100830","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2213538326001311/pdf","source":{"id":"https://openalex.org/S2764631794","display_name":"Journal of Cancer Policy","issn_l":"2213-5383","issn":["2213-5383"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Policy","raw_type":"journal-article"},{"id":"pmid:42994563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42994563","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cancer policy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jcpo.2026.100830","doi":"https://doi.org/10.1016/j.jcpo.2026.100830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcpo.2026.100830","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2213538326001311/pdf","source":{"id":"https://openalex.org/S2764631794","display_name":"Journal of Cancer Policy","issn_l":"2213-5383","issn":["2213-5383"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Policy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225433364.pdf","grobid_xml":"https://content.openalex.org/works/W7225433364.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1937020882","https://openalex.org/W2109314733","https://openalex.org/W2212551923","https://openalex.org/W2343598183","https://openalex.org/W2570174586","https://openalex.org/W2761792472","https://openalex.org/W2911634114","https://openalex.org/W2947583588","https://openalex.org/W2999450719","https://openalex.org/W3014115276","https://openalex.org/W3103479524","https://openalex.org/W3164911512","https://openalex.org/W4211143946","https://openalex.org/W4281743187","https://openalex.org/W4315977409","https://openalex.org/W4384501847","https://openalex.org/W4386448441","https://openalex.org/W4393188417","https://openalex.org/W4405186765"],"related_works":["https://openalex.org/W4255214154","https://openalex.org/W2527869139","https://openalex.org/W2070257693","https://openalex.org/W7224958036","https://openalex.org/W4250379212","https://openalex.org/W4405439155","https://openalex.org/W7147602559","https://openalex.org/W1989955257","https://openalex.org/W4413720642","https://openalex.org/W4416257135"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,104,169],"approval":[2],"of":[3,15,30,52,134,154,158,238,248],"oncology":[4,34,219],"therapies":[5,35,136,160,220,231,252],"has":[6],"increasingly":[7],"incorporated":[8],"biomarker-driven":[9],"precision":[10],"medicine.":[11],"However,":[12],"the":[13,27,39,90,132,189,236,239,258,284],"influence":[14],"mandatory":[16,81,222],"biomarker":[17,82,223],"selection":[18,88,224],"on":[19,279],"regulatory":[20,28,106],"pathways":[21],"remains":[22],"poorly":[23],"understood.":[24],"We":[25,47],"compared":[26],"characteristics":[29,94],"targeted":[31,79,120,135,155,251],"and":[32,44,64,72,95,122,185,272,275,283],"non-targeted":[33,124,159,230],"first":[36,59],"authorised":[37,60],"in":[38,89,131,195],"European":[40,65],"Union":[41],"between":[42,69],"2015":[43,71],"2025.":[45,74],"METHODS:":[46],"conducted":[48],"a":[49],"retrospective":[50],"analysis":[51],"drug-indication":[53,115],"pairs":[54,116],"for":[55,86,178],"malignant":[56],"solid":[57],"tumours":[58],"following":[61],"EMA":[62,102],"assessment":[63],"Commission":[66],"marketing":[67,200],"authorisation":[68,201],"January":[70],"December":[73],"Therapies":[75],"were":[76,97,117,225],"classified":[77],"as":[78],"when":[80],"testing":[83],"was":[84,108,137,150,202,241],"required":[85],"patient":[87],"approved":[91],"indication.":[92],"Regulatory":[93],"timelines":[96],"obtained":[98],"from":[99],"publicly":[100],"available":[101],"information.":[103],"primary":[105],"outcome":[107],"Conditional":[109],"Marketing":[110],"Authorisation":[111],"(CMA).":[112],"RESULTS:":[113],"Eighty":[114],"included:":[118],"45":[119],"(56.3%)":[121],"35":[123],"(43.8%).":[125],"No":[126,192],"significant":[127,193],"linear":[128],"temporal":[129],"trend":[130],"proportion":[133],"detected":[138,203],"(OR":[139,161],"per":[140],"year":[141],"1.15;":[142],"95%":[143,163,213],"CI":[144,164,215],"1.00-1.33;":[145],"p":[146,166],"=":[147],"0.051).":[148],"CMA":[149,249],"granted":[151],"to":[152,199,232,270],"42.2%":[153],"versus":[156],"5.7%":[157],"12.06;":[162],"2.57-56.53;":[165],"<":[167],"0.001).":[168],"association":[170,240],"remained":[171],"directionally":[172],"consistent":[173],"across":[174],"sensitivity":[175],"analyses":[176],"accounting":[177],"calendar":[179],"year,":[180],"pharmacological":[181],"class,":[182],"tumour":[183],"type,":[184],"multiple":[186],"indications":[187,256],"within":[188],"same":[190],"application.":[191],"difference":[194,210],"total":[196],"elapsed":[197],"time":[198],"(median":[204],"419":[205],"vs":[206],"427":[207],"days;":[208],"median":[209],"-":[211],"8days;":[212],"bootstrap":[214],"-52-21).":[216],"CONCLUSIONS:":[217],"Targeted":[218],"requiring":[221],"substantially":[226],"more":[227,255],"likely":[228],"than":[229],"receive":[233],"CMA,":[234],"although":[235],"magnitude":[237],"imprecisely":[242],"estimated.":[243],"POLICY":[244],"SUMMARY:":[245],"Greater":[246],"use":[247],"among":[250],"means":[253],"that":[254],"enter":[257],"post-authorisation":[259],"period":[260],"with":[261],"confirmatory":[262],"evidence":[263,285],"obligations":[264,282],"outstanding.":[265],"This":[266],"may":[267],"be":[268],"relevant":[269],"HTA":[271],"reimbursement":[273],"decisions":[274],"warrants":[276],"longitudinal":[277],"research":[278],"how":[280],"these":[281],"base":[286],"evolve":[287],"after":[288],"authorisation.":[289]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-07T00:00:00"}